dragonlinkslotmachine| Biotech Shares (600201.SH): Subsidiary obtains approval number for veterinary drug product approval number

Gelonghui May 27 丨 Biological Shares (600201)(600201dragonlinkslotmachine.SH) AnnouncementdragonlinkslotmachineIn accordance with the "Regulations on the Administration of Veterinary Drugs","Measures for Veterinary Drugs Registration" and "Work Procedures for Veterinary Drugs Registration and Review"(Announcement No. 392 of the Ministry of Agriculture and Rural Affairs of the People's Republic of China), after review by the Ministry of Agriculture and Rural Affairs, the company's wholly-owned subsidiary Jinyu Baoling Biopharmaceutical Co., Ltd.(referred to as "Jinyu Baoling") is allowed to produce inactivated bovine nodular dermatosis vaccine (NMG strain, suspension culture), and a temporary veterinary drug product approval number was issued.

dragonlinkslotmachine| Biotech Shares (600201.SH): Subsidiary obtains approval number for veterinary drug product approval number

Bovine nodular dermatosis is a systemic infectious disease in cattle caused by bovine nodular dermatosis virus. It is mainly characterized by fever, skin edema and local hard nodules or ulcers. It affects the production performance of beef cattle, dairy cow milk yield, and breeding bull reproductive performance, damage skin sheets, thereby causing serious economic losses. The strain used in the inactivated bovine nodular dermatosis vaccine (NMG strain, suspension culture) matches the genotype of the domestic epidemic strain of bovine nodular dermatosis and has good immunogenicity. This product is a veterinary drug needed for the emergency response of major animal diseases in my country. It helps purify the disease and helps the healthy development of the cattle industry.

Powered By Z-BlogPHP 1.7.3